Researchers at Helwan University studied the risk of HCC susceptibility in Egyptian patients with hepatitis C after SVR through DAA treatment and found that the CHI3L1 gene (rs880633) could serve as a strong predictor and risk factor for patients to develop HCC post-SVR (67). Here, CHI3L1 is linked to hepatocellular carcinoma.